Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yang Yang, Ke Wang, Hao Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113001-113001
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
Sadique A. Javed, Asim Najmi, Waquar Ahsan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases
Christian Bailly, Xavier Thuru, Bruno Quesnel
Cancers (2021) Vol. 13, Iss. 12, pp. 3034-3034
Open Access | Times Cited: 94
Small molecule-based immunomodulators for cancer therapy
Yinrong Wu, Zichao Yang, Kui Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4287-4308
Open Access | Times Cited: 62
Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
Pottayil G. Sasikumar, Murali Ramachandra
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 22
Design, Synthesis, and Evaluation of o-(Biphenyl-3-ylmethoxy)nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy In Vivo
Yiqiang Ouyang, Jian Gao, Lei Zhao, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7646-7666
Closed Access | Times Cited: 40
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2638-2638
Open Access | Times Cited: 19
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 6
Small-molecule modulators of tumor immune microenvironment
Jing Zhang, Jia Yu, Meijing Liu, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107251-107251
Closed Access | Times Cited: 5
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Inside PD-1/PD-L1,2 with their inhibitors
Nicolas Boisgerault, Philìppe Bertrand
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115465-115465
Open Access | Times Cited: 14
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents
Jin Liu, Yao Cheng, L. Yuan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13172-13188
Closed Access | Times Cited: 13
Progress in small-molecule inhibitors targeting PD-L1
J. Xu, Yuanfang Kong, Pengbo Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1161-1175
Closed Access | Times Cited: 4
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
Ewa Surmiak, Katarzyna Magiera‐Mularz, Bogdan Musielak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11797-11797
Open Access | Times Cited: 27
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction
Pujan Sasmal, B. Sajeev Kumar, B. R. Prashantha Kumar, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117001-117001
Closed Access | Times Cited: 18
Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold
Shi Cai, Kaizhen Wang, Zhihao Qi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115468-115468
Closed Access | Times Cited: 11
Generation, secretion and degradation of cancer immunotherapy target PD-L1
Dandan Shen, Ya‐Ping Bi, Jing‐Ru Pang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 14
Design, synthesis, and biological evaluation of 1-methyl-1H-pyrazolo[4,3-b]pyridine derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction
Xinyan Dai, Ke Wang, Hao Chen, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105034-105034
Closed Access | Times Cited: 19
Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold
Hao Chen, Ke Wang, Yang Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113377-113377
Closed Access | Times Cited: 14
Advances of Biphenyl Small-Molecule Inhibitors Targeting PD-1/PD-L1 Interaction in Cancer Immunotherapy
Roufen Chen, Dandan Yuan, Junjie Ma
Future Medicinal Chemistry (2021) Vol. 14, Iss. 2, pp. 97-113
Closed Access | Times Cited: 14
Effects of small molecule-induced dimerization on the programmed death ligand 1 protein life cycle
Ilean Chai, Dmytro Kornyeyev, Edward J. Hsieh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors
Qian Dong, Mengya Tong, Xiaolu Yu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7179-7204
Closed Access | Times Cited: 5
Synthesis and preliminary evaluation of aminophenol derivatives as molecular glues blocking PD-1/PD-L1 interaction
Qiaohong Geng, Yanyan Dong, Jin Peng, et al.
Journal of Molecular Structure (2023) Vol. 1289, pp. 135900-135900
Closed Access | Times Cited: 5
De Novo Synthesis of Dihydrobenzofurans and Indolines and Its Application to a Modular, Asymmetric Synthesis of Beraprost
Ze‐Shu Wang, Steven H. Bennett, Bilal Kicin, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 25, pp. 14124-14132
Open Access | Times Cited: 5
Synthesis and evaluation of indole-containing derivatives as C-linked PD-L1 inhibitors for cancer immunotherapy
Qiaohong Geng, Yanyan Dong, Peng Jin, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136487-136487
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top